RxDataScience (RxDS), a start-up focused on the pharmaceutical and healthcare landscape, has selected Kx technology to power its data science platform.
Kx, part of global technology provider FD, specialises in high-performance in-memory computing, streaming analytics and operational intelligence.
RxDS was selected for its capability to ingest, process and analyse large volumes of historical and streaming data in real time.
In particular, Kx can combine different large datasets to provide a holistic view for clients within a single platform.
Kx will generate predictive analytics insights from terabyte volumes of patient medical, claims and lab records incorporating billions of rows of data.
Until now, these analytical technologies were only used by the most prestigious financial services firms on Wall Street.
These solutions are purpose-built applications, such as Rare Disease Patient Finder; Longitudinal Patient Data Analyser; New Product Launch Accelerator; and Predictive Managed Markets Analytics.
The solutions are then tailored for individual customers’ markets.
Larry Pickett, Chief Executive Officer of RxDataScience said: “Its lightning fast in-memory columnar time series database provides unmatched speed and flexibility.”
“This will help identify trends quickly and enable better decision making across their organisations.”
“Until now, these analytical technologies were only used by the most prestigious financial services firms on Wall Street. We are now bringing Kx technology to pharma and healthcare.”
